Invitrogen

AADAC Polyclonal Antibody

图: 1 / 1

AADAC Antibody (PA5-109351) in WB

Western blot analysis of AADAC in extracts of various cell lines. Samples were incubated with AADAC Polyclonal antibody (Product # PA5-109351) using a dilution of 1:1,000, followed by HRP Goat Anti-Rabbit IgG (H+L) at a dilution of 1:10,000. Lysates/proteins: 25 µg per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 30s.

Product Image Gallery

产品信息

PA5-109351

应用

建议稀释比

已发表文章

免疫印迹 (WB)

1:500-1:2,000

酶联免疫吸附实验 (ELISA)

1 µg/mL

产品规格

种属反应

Human, Mouse

宿主/亚型

Rabbit / IgG

分类

Polyclonal

类型

Antibody

抗原

Recombinant fusion protein containing a sequence corresponding to amino acids 170-399 of human AADAC (NP_001077.2).

查看免疫原

偶联物

Unconjugated Unconjugated Unconjugated

形式

Liquid

浓度

1.26 mg/mL

纯化类型

Affinity Chromatography

保存液

PBS, pH 7.3, with 50% glycerol

内含物

0.02% sodium azide

保存条件

-20° C, Avoid Freeze/Thaw Cycles

运输条件

Wet ice

AB_2854762

产品详细信息

Immunogen sequence: KKVLAKYGVN PERIGISGDS AGGNLAAAVT QQLLDDPDVK IKLKIQSLIY PALQPLDVDL PSYQENSNFL FLSKSLMVRF WSEYFTTDRS LEKAMLSRQH VPVESSHLFK FVNWSSLLPE RFIKGHVYNN PNYGSSELAK KYPGFLDVRA APLLADDNKL RGLPLTYVIT CQYDLLRDDG LMYVTRLRNT GVQVTHNHVE DGFHGAFSFL GLKISHRLIN QYIEWLKENL

靶标信息

Microsomal arylacetamide deacetylase competes against the activity of cytosolic arylamine N-acetyltransferase, which catalyzes one of the initial biotransformation pathways for arylamine and heterocyclic amine carcinogens.Microsomal arylacetamide deacetylase competes against the activity of cytosolic arylamine N-acetyltransferase, which catalyzes one of the initial biotransformation pathways for arylamine and heterocyclic amine carcinogens.Microsomal arylacetamide deacetylase competes against the activity of cytosolic arylamine N-acetyltransferase, which catalyzes one of the initial biotransformation pathways for arylamine and heterocyclic amine carcinogens.

仅用于科研。不用于诊断过程。未经明确授权不得转售。